Ronald Duman, Ph.D.
Dr. Duman is a Professor of Psychiatry and Pharmacology and the Director of the Abraham Ribicoff Research Facilities. His work has focused on antidepressants and stress at the molecular and cellular levels, providing the groundwork for a hypothesis of depression based on the maintenance and survival of neurons, or neurotrophy. This hypothesis is based on work demonstrating that chronic antidepressant treatment increases the proliferation of new neurons (or neurogenesis) in the adult brain. These effects counteract the atrophy and cell loss that is caused...
Richard A. Friedman, M.D.
Dr. Friedman is Professor of Clinical Psychiatry at Weill Cornell Medical College and Director of the Psychopharmacology Clinic in the Department of Psychiatry. Dr. Friedman has interest and expertise in the psychopharmacology and neurobiology of mood disorders and, in particular, treatment-resistant depression. At Cornell, he is actively involved in teaching and training psychiatric residents and medical students. He also does research in depressive disorders, including studies of new medications for depression and a large collaborative study of the genetics and neurobiology of bipolar disorder.
Dr....
Ian Gotlib, Ph.D.
Dr. Gotlib is Professor of Psychology and Director of the Stanford Mood and Anxiety Disorders Laboratory. He joined the faculty at Stanford University in 1996, and became Senior Associate Dean of the Social Sciences in 2005.
In his research, Dr. Gotlib broadly examines psychological and biological factors that place individuals at increased risk for depression, as well as processes that are involved in recovery from this disorder. A major goal of his research is to develop a more comprehensive and integrative psychobiological model of the...